Gómez-Bernal, Fuensanta
Quevedo-Abeledo, Juan Carlos
García-González, María
Fernández-Cladera, Yolanda
González-Rivero, Agustín F.
Martín-González, Candelaria
González-Gay, Miguel Á.
Ferraz-Amaro, Iván
Article History
Received: 26 October 2022
Accepted: 5 April 2023
First Online: 17 April 2023
Declarations
:
: The study protocol was approved by the institutional review committees at Hospital Universitario.de Canarias and Hospital Universitario Doctor Negrín, and all subjects provided written informedconsent.
: Not applicable.
: Dr. Iván Ferraz-Amaro would like to acknowledge that he has received grants/research supports from Abbott, MSD, Janssen, and Roche, as well as consultation fees from company-sponsored speakers bureaus associated with Abbott, Pfizer, Roche, Sanofi, Celgene, and MSD. Dr. M.A. GonzÁlez-Gay has received grants/research supports from AbbVie, MSD, Janssen, and Roche, as well as consultation fees/participation from company-sponsored speakers bureaus tied to AbbVie, Pfizer, Roche, Sanofi, Lilly, Celgene, and MSD. The other authors declare that they have no competing interests.